Section 130 Penalty on Excessive Prescription Drug Price Growth 2

Notwithstanding any general or special law to the contrary, no penalty shall be assessed under chapter 63E of the General Laws, as inserted by section 41, until the calendar quarter beginning October 1, 2025.

This section, together with a related section, establishes a penalty on drug manufacturers who increase prices on a prescription drug in excess of the change in the Consumer Price Index.